BLM and Bloom syndrome: In addition to analyzing a Bloom-syndrome-patient-derived cell line (BLM−/−, GM08505) we constructed a BLM-knockout cell line by CRISPR/Cas9-mediated disruption of BLM exon 8 in the human skin fibroblast cell line GM00637.